Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

NCT06172660 · clinicaltrials.gov ↗

RECRUITING

Status

3750

Enrollment

OTHER

Sponsor class

Conditions

RSV Infection

Interventions

DRUG: Nirsevimab

Sponsor

Yale University

Collaborators

[object Object]